The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
October 8th 2024At the 2024 World Conference on Lung Cancer, Ana Baramidze, MD, PhD, presented 5-year outcomes of the trial, which investigated cemiplimab monotherapy in first-line advanced non–small cell lung cancer (NSCLC) with PD-L1 expression of 50% or greater.
Watch
The Hidden Pulse: AI-Enabled Remote Cardiac Monitoring Is at the Heart of Healthier Sleep
October 8th 2024AI-enabled remote cardiac monitoring offers continuous data on heart activity, allowing for the early detection of arrhythmias, optimized treatment timing, and improved sleep-related heart health management.
Read More
Exploring the CARMEN-LCO3 Trial: Tusamitamab Ravtansine vs Docetaxel in Advanced Non-Squamous NSCLC
October 7th 2024At the 2024 World Conference on Lung Cancer, Benjamin Besse, MD, PhD, discussed the findings of the phase 3 CARMEN-LCO3 trial, which led to the discontinuation of the study drug by the manufacturer.
Watch
IVIG, Plasmapheresis Comparable in Long-Term Efficacy for Treatment of Myasthenic Crisis
October 7th 2024Though both treatments come with positives and negatives, ultimately, individual patient clinical presentation and accessibility will determine the proper treatment for myasthenic crisis.
Read More
Emergency Prescription Assistance Program Deployed in North Carolina Following Hurricane Helene
October 7th 2024Eligible patients can receive a 30-day supply of covered drugs and medical supplies that can be renewed every 30 days for as long as an Emergency Prescription Assistance Program (EPAP) is active.
Read More
Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
October 4th 2024When considering the 3-stage framework, perhaps a greater emphasis on pre-treatment phase research could help identify some of the more individual traits used to better predict patient outcomes.
Read More